UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effect of biochar on carbon fractions and enzyme activity of red soil

Catena (Giessen), 2014-10, Vol.121, p.214-221

2014

Volltextzugriff (PDF)

Role of GPX4-Mediated Ferroptosis in the Sensitivity of Triple Negative Breast Cancer Cells to Gefitinib

Frontiers in oncology, 2020-12, Vol.10, p.597434-597434

2020

Volltextzugriff (PDF)

Simulated degradation of biochar and its potential environmental implications

Environmental pollution (1987), 2013-08, Vol.179, p.146-152

2013

Volltextzugriff (PDF)

Predictive Role of Immune Profiling for Survival of Multiple Myeloma Patients

Frontiers in immunology, 2021-07, Vol.12, p.663748-663748

2021

Volltextzugriff (PDF)

Cyperotundone combined with adriamycin induces apoptosis in MCF-7 and MCF-7/ADR cancer cells by ROS generation and NRF2/ARE signaling pathway

Scientific reports, 2023-01, Vol.13 (1), p.1384-1384, Article 1384

2023

Volltextzugriff (PDF)

Role of EZH2 in bone marrow mesenchymal stem cells and immune–cancer interactions

Critical reviews in oncology/hematology, 2022-01, Vol.169, p.103547-103547, Article 103547

2022

Volltextzugriff (PDF)

Study on the Effect of EZH2 Inhibitor Combined with TIGIT Monoclonal Antibody against Multiple Myeloma Cells

International journal of molecular sciences, 2023-05, Vol.24 (10), p.8603

2023

Volltextzugriff (PDF)

Overexpression of TIGIT in NK and T Cells Contributes to Tumor Immune Escape in Myelodysplastic Syndromes

Frontiers in oncology, 2020-08, Vol.10, p.1595-1595

2020

Volltextzugriff (PDF)

Autophagy inhibitor facilitates gefitinib sensitivity in vitro and in vivo by activating mitochondrial apoptosis in triple negative breast cancer

PloS one, 2017-05, Vol.12 (5), p.e0177694

2017

Volltextzugriff (PDF)

Immunogenic Cell Death in Hematological Malignancy Therapy

Advanced science, 2023-05, Vol.10 (13), p.e2207475-n/a

2023

Volltextzugriff (PDF)

Adenosinergic axis and immune checkpoint combination therapy in tumor: A new perspective for immunotherapy strategy

Frontiers in immunology, 2022-09, Vol.13, p.978377-978377

2022

Volltextzugriff (PDF)

Investigation of Candidate Genes and Pathways in Basal/TNBC Patients by Integrated Analysis

Technology in cancer research & treatment, 2021-01, Vol.20, p.15330338211019506-15330338211019506

2021

Volltextzugriff (PDF)

The immunological role of mesenchymal stromal cells in patients with myelodysplastic syndrome

Frontiers in immunology, 2022-12, Vol.13, p.1078421-1078421

2022

Volltextzugriff (PDF)

Computing cell state discriminates the aberrant hematopoiesis and activated microenvironment in Myelodysplastic syndrome (MDS) through a single cell genomic study

Journal of translational medicine, 2024-07, Vol.22 (1), p.673-16, Article 673

2024

Volltextzugriff (PDF)

Therapeutic strategies to enhance immune response induced by multiple myeloma cells

Frontiers in immunology, 2023-05, Vol.14, p.1169541-1169541

2023

Volltextzugriff (PDF)

PR status is a more decisive factor in efficacy of adding pertuzumab into neoadjuvant therapy for HER2-positive and lymph node-positive breast cancer than ER status: a real-world retrospective study in China

World journal of surgical oncology, 2023-09, Vol.21 (1), p.1-296, Article 296

2023

Volltextzugriff (PDF)

Challenges and strategies associated with CAR-T cell therapy in blood malignancies

Experimental hematology & oncology, 2024-02, Vol.13 (1), p.22-22, Article 22

2024

Volltextzugriff (PDF)

An overview of pim kinase as a target in multiple myeloma

Cancer medicine (Malden, MA), 2023-05, Vol.12 (10), p.11746-11759

2023

Volltextzugriff (PDF)

The residual cancer burden index as a valid prognostic indicator in breast cancer after neoadjuvant chemotherapy

BMC cancer, 2024-01, Vol.24 (1), p.13-13, Article 13

2024

Volltextzugriff (PDF)

Construction of a risk stratification model integrating ctDNA to predict response and survival in neoadjuvant-treated breast cancer

BMC medicine, 2023-12, Vol.21 (1), p.493-493, Article 493

2023

Volltextzugriff (PDF)

Immune checkpoint inhibitors for multiple myeloma immunotherapy

Experimental hematology & oncology, 2023-11, Vol.12 (1), p.1-99, Article 99

2023

Volltextzugriff (PDF)

The value of serum IL-4 to predict the survival of MDS patients

European journal of medical research, 2023-01, Vol.28 (1), p.7-7, Article 7

2023

Volltextzugriff (PDF)

P710: MONOCYTES MEDIATE NK CELL FUNCTION EXHAUSTION IN MDS PATIENTS VIA CD200/CD200R PATHWAY

HemaSphere, 2023-08, Vol.7 (S3), p.e9941541-n/a

2023

Volltextzugriff (PDF)

P811: PIM2 KINASE REGULATES TIGIT EXPRESSION AND ENERGY METABOLISM IN NK CELLS OF PATIENTS WITH MULTIPLE MYELOMA

HemaSphere, 2023-08, Vol.7 (S3), p.e33905c7-n/a

2023

Volltextzugriff (PDF)

PB2136: THE VALUE OF PERIPHERAL BLOOD LYMPHOCYTE SUBSETS IN PREDICTING THE PROGNOSIS OF NEWLY DIAGNOSED MULTIPLE MYELOMA

HemaSphere, 2023-08, Vol.7 (S3), p.e9470085-n/a

2023

Volltextzugriff (PDF)

1 – 25 von 539

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(428)
Mit Volltextzugriff
(473)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(376)
Life Sciences & Biomedicine
(222)
Technology
(107)
Humans
(92)
Physical Sciences
(87)
Engineering
(68)
Oncology
(59)
Male
(47)
Female
(44)
Physics
(40)
Engineering, Electrical & Electronic
(38)
Animals
(37)
Proteins
(36)
Apoptosis
(34)
Medicine, Research & Experimental
(32)
Research & Experimental Medicine
(32)
Middle Aged
(31)
Multiple Myeloma
(30)
Adult
(27)
Materials Science
(26)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(13)

Menü

Weitere Dienste

Einstellungen

Effect of biochar on carbon fractions and enzyme activity of red soil

Role of GPX4-Mediated Ferroptosis in the Sensitivity of Triple Negative Breast Cancer Cells to Gefitinib

Simulated degradation of biochar and its potential environmental implications

Predictive Role of Immune Profiling for Survival of Multiple Myeloma Patients

Cyperotundone combined with adriamycin induces apoptosis in MCF-7 and MCF-7/ADR cancer cells by ROS generation and NRF2/ARE signaling pathway

Role of EZH2 in bone marrow mesenchymal stem cells and immune–cancer interactions

Study on the Effect of EZH2 Inhibitor Combined with TIGIT Monoclonal Antibody against Multiple Myeloma Cells

Overexpression of TIGIT in NK and T Cells Contributes to Tumor Immune Escape in Myelodysplastic Syndromes

Autophagy inhibitor facilitates gefitinib sensitivity in vitro and in vivo by activating mitochondrial apoptosis in triple negative breast cancer

Immunogenic Cell Death in Hematological Malignancy Therapy

Adenosinergic axis and immune checkpoint combination therapy in tumor: A new perspective for immunotherapy strategy

Investigation of Candidate Genes and Pathways in Basal/TNBC Patients by Integrated Analysis

The immunological role of mesenchymal stromal cells in patients with myelodysplastic syndrome

Computing cell state discriminates the aberrant hematopoiesis and activated microenvironment in Myelodysplastic syndrome (MDS) through a single cell genomic study

Therapeutic strategies to enhance immune response induced by multiple myeloma cells

PR status is a more decisive factor in efficacy of adding pertuzumab into neoadjuvant therapy for HER2-positive and lymph node-positive breast cancer than ER status: a real-world retrospective study in China

Challenges and strategies associated with CAR-T cell therapy in blood malignancies

An overview of pim kinase as a target in multiple myeloma

The residual cancer burden index as a valid prognostic indicator in breast cancer after neoadjuvant chemotherapy

Construction of a risk stratification model integrating ctDNA to predict response and survival in neoadjuvant-treated breast cancer

Immune checkpoint inhibitors for multiple myeloma immunotherapy

The value of serum IL-4 to predict the survival of MDS patients

P710: MONOCYTES MEDIATE NK CELL FUNCTION EXHAUSTION IN MDS PATIENTS VIA CD200/CD200R PATHWAY

P811: PIM2 KINASE REGULATES TIGIT EXPRESSION AND ENERGY METABOLISM IN NK CELLS OF PATIENTS WITH MULTIPLE MYELOMA

PB2136: THE VALUE OF PERIPHERAL BLOOD LYMPHOCYTE SUBSETS IN PREDICTING THE PROGNOSIS OF NEWLY DIAGNOSED MULTIPLE MYELOMA

Suchergebnisse filtern